Erik Thunnissen

Active 1992–2024

119
Papers
33,136
Citations
82
h-index
116
i10-index

Citations

Citations per year for Erik Thunnissen1963: 1 citations1971: 1 citations1976: 1 citations1986: 1 citations1989: 1 citations1990: 1 citations1993: 2 citations1994: 7 citations1995: 8 citations1996: 13 citations1997: 24 citations1998: 27 citations1999: 28 citations2000: 33 citations2001: 40 citations2002: 52 citations2003: 49 citations2004: 50 citations2005: 57 citations2006: 75 citations2007: 61 citations2008: 66 citations2009: 53 citations2010: 70 citations2011: 126 citations2012: 177 citations2013: 267 citations2014: 272 citations2015: 328 citations2016: 340 citations2017: 293 citations2018: 307 citations2019: 1,099 citations2020: 1,426 citations2021: 1,464 citations2022: 1,154 citations2023: 824 citations2024: 1,259 citations2025: 513 citations2026: 18 citations1964–1970: no citations, so these years are not shown1972–1975: no citations, so these years are not shown1977–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,499 citing papers, 24% of this breakdownChina: 1,846 citing papers, 12.7% of this breakdownUnited Kingdom: 923 citing papers, 6.3% of this breakdownItaly: 771 citing papers, 5.3% of this breakdownGermany: 693 citing papers, 4.8% of this breakdownJapan: 671 citing papers, 4.6% of this breakdownNetherlands: 611 citing papers, 4.2% of this breakdownFrance: 592 citing papers, 4.1% of this breakdownSpain: 486 citing papers, 3.3% of this breakdownCanada: 449 citing papers, 3.1% of this breakdownSouth Korea: 382 citing papers, 2.6% of this breakdownAustralia: 356 citing papers, 2.5% of this breakdown
0%24%Other 22.5%

Fields

  • Medicine73.7%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Computer Science1.3%
  • Engineering1%
  • Immunology and Microbiology1%
  • Nursing0.7%
  • Other1.9%

Topics

  • Lung Cancer Treatments and Mutations10.7%
  • Lung Cancer Diagnosis and Treatment10.3%
  • Lung Cancer Research Studies7.3%
  • Cancer Immunotherapy and Biomarkers4.6%
  • Cancer Genomics and Diagnostics4.4%
  • Radiomics and Machine Learning in Medical Imaging4.3%
  • Other58.4%

Coauthors

All papers

Open in search
  1. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 3,475

  2. Comprehensive genomic profiles of small cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Danila Seidel, Berit Pinther, Philipp Schaub, Christian Becker, Janine Altmüller, Jun Yokota, Takashi Kohno, Reika Iwakawa, Koji Tsuta, Masayuki Noguchi, Thomas Muley, Hans Hoffmann, Philipp A. Schnabel, Iver Petersen, Yuan Chen, Alex Soltermann, Verena Tischler, Chang‐Min Choi, Yong‐Hee Kim, Pierre P. Massion, Yong Zou, Dragana J. Jovanović, Milica Kontić, Gavin Wright, Prudence A. Russell, Benjamin Solomon, Ina Koch, Michael Lindner, Lucia Anna Muscarella, Annamaria la Torre, John K. Field, Marko Jakopović, Jelena Knežević, Esmeralda Castaños‐Vélez, Luca Roz, Ugo Pastorino, O.T. Brustugun, Marius Lund‐Iversen, Erik Thunnissen, Jens Köhler, Martin Schüler, Johan Botling, Martin Sandelin, Montse Sánchez‐Céspedes, Helga B. Salvesen, Viktor Achter, Ulrich Lang, Magdalena Bogus, Peter M. Schneider, Thomas Zander, Sascha Ansén, Michael Hallek, Jürgen Wolf, Martin Vingron, Yasushi Yatabe, William D. Travis, Peter Nürnberg, Christian Reinhardt, Sven Perner, Lukas C. Heukamp, Reinhard Büttner, Stefan A. Haas, Élisabeth Brambilla, Martin Peifer, Julien Sage, Roman K. Thomas - Nature 2015 cited by 2,428

  3. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 cited by 4,843

  4. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 cited by 541

  5. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 cited by 450

  6. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 cited by 1,418

  7. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 931

  8. PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 cited by 807

  9. Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 483

  10. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Yatabe, Akihiko Yoshida, Jillian B. Daigneault, Ahmet Zehir, Solange Peters, Ignacio I. Wistuba, Keith M. Kerr, John Longshore - Journal of Thoracic Oncology 2020 cited by 292

  11. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

    Authors: , , , , , , , , , - Lung Cancer 2021 cited by 201

  12. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Molecular Diagnostics 2018 cited by 633

  13. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ignacio I. Wistuba, André L. Moreira - Journal of Thoracic Oncology 2018 cited by 353

  14. PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2021 cited by 87

  15. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Giuseppe Pelosi, Claudia Poleri, William D. Travis, Akihiko Yoshida, Jillian B. Daigneault, Ignacio I. Wistuba, Mari Mino–Kenudson - Journal of Thoracic Oncology 2019 cited by 345

  16. Management of Lung Nodules Detected by Volume CT Scanning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 822

  17. Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial

    Authors: , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2013 cited by 274

  18. Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer

    Authors: , , , , , , , , , , , - Journal of Nuclear Medicine 2021 cited by 85

  19. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers

    Authors: , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 382

  20. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

    Authors: , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2013 cited by 1,284

  21. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Birgit I. Lissenberg‐Witte, Dirk J. Kuik - Modern Pathology 2012 cited by 241

  22. Rapid On-Site Evaluation of Endobronchial Ultrasound–Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

    Authors: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2017 cited by 182

  23. Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports 2014 cited by 316

  24. Number and Proliferation of Basal and Parabasal Cells in Normal Human Airway Epithelium

    Authors: , , - American Journal of Respiratory and Critical Care Medicine 1998 cited by 281